OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control
Yosra A. Helmy, Mohamed Fawzy, Ahmed Elaswad, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 4, pp. 1225-1225
Open Access | Times Cited: 683

Showing 26-50 of 683 citing articles:

Global data analysis and risk factors associated with morbidity and mortality of COVID-19
Sina Salajegheh Tazerji, Fatemeh Shahabinejad, Mahya Tokasi, et al.
Gene Reports (2022) Vol. 26, pp. 101505-101505
Open Access | Times Cited: 76

Assessing the effect of the COVID-19 pandemic, shift to online learning, and social media use on the mental health of college students in the Philippines: A mixed-method study protocol
Leonard Thomas S. Lim, Zypher Jude G. Regencia, J. Rem C. Dela Cruz, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0267555-e0267555
Open Access | Times Cited: 69

Salmonellosis: An Overview of Epidemiology, Pathogenesis, and Innovative Approaches to Mitigate the Antimicrobial Resistant Infections
Bibek Lamichhane, Asmaa M. M. Mawad, Mohammed A. Saleh, et al.
Antibiotics (2024) Vol. 13, Iss. 1, pp. 76-76
Open Access | Times Cited: 63

A Bibliometric Analysis of COVID-19 across Science and Social Science Research Landscape
Aleksander Aristovnik, Dejan Ravšelj, Lan Umek
Sustainability (2020) Vol. 12, Iss. 21, pp. 9132-9132
Open Access | Times Cited: 135

Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals
Daniel W. Kneller, Stephanie Galanie, G.N. Phillips, et al.
Structure (2020) Vol. 28, Iss. 12, pp. 1313-1320.e3
Open Access | Times Cited: 123

Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis
Angelo Santoliquido, Angelo Porfidia, Antonio Nesci, et al.
Journal of Thrombosis and Haemostasis (2020) Vol. 18, Iss. 9, pp. 2358-2363
Open Access | Times Cited: 117

Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review
Sina Salajegheh Tazerji, Phelipe Magalhães Duarte, Parastoo Rahimi, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 117

Remote Patient Monitoring Program for Hospital Discharged COVID-19 Patients
William J. Gordon, Daniel Henderson, Avital DeSharone, et al.
Applied Clinical Informatics (2020) Vol. 11, Iss. 05, pp. 792-801
Open Access | Times Cited: 115

Male Fertility and the COVID-19 Pandemic: Systematic Review of the Literature
Mohammad Ali Khalili, Kristian Leisegang, Ahmad Majzoub, et al.
The World Journal of Men s Health (2020) Vol. 38, Iss. 4, pp. 506-506
Open Access | Times Cited: 112

Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients
Junaid Mushtaq, Renato Pennella, Salvatore Lavalle, et al.
European Radiology (2020) Vol. 31, Iss. 3, pp. 1770-1779
Open Access | Times Cited: 110

Acceptance and Attitudes Toward COVID-19 Vaccines: A Cross-Sectional Study from Jordan
Tamam El‐Elimat, Mahmoud M. AbuAlSamen, Basima A. Almomani, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 90

Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic
Chase W. Nelson, Zachary Ardern, Tony L. Goldberg, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 88

Impact of Early Pandemic Stage Mutations on Molecular Dynamics of SARS-CoV-2 Mpro
Olivier Sheik Amamuddy, Gennady M. Verkhivker, Özlem Taştan Bishop
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 10, pp. 5080-5102
Open Access | Times Cited: 83

COVID-19 pandemic: current knowledge about the role of pets and other animals in disease transmission
Mulugeta Kiros, Andualem Henok, Teklehaimanot Kiros, et al.
Virology Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 82

COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic
Valamla Bhavana, Pradip Thakor, Shashi Bala Singh, et al.
Life Sciences (2020) Vol. 261, pp. 118336-118336
Open Access | Times Cited: 81

Repurposing anticancer drugs for the management of COVID-19
Khalid El Bairi, Dario Trapani, Angelica Petrillo, et al.
European Journal of Cancer (2020) Vol. 141, pp. 40-61
Open Access | Times Cited: 80

Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models
Kirill V. Kalnin, Timothy Plitnik, Michael Kishko, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 77

Outbreak of COVID-19: An emerging global pandemic threat
Minhua Peng
Biomedicine & Pharmacotherapy (2020) Vol. 129, pp. 110499-110499
Open Access | Times Cited: 73

Review on Up-to-Date Status of Candidate Vaccines for COVID-19 Disease
Tafere Mulaw Belete
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 151-161
Open Access | Times Cited: 73

New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19
Muneerah M Aleissa, Emily A. Silverman, Luisa M. Paredes Acosta, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 65, Iss. 1
Open Access | Times Cited: 71

Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach
N. Arul Murugan, Sanjiv Kumar, Jeyaraman Jeyakanthan, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 70

Nanotechnology Against The Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2): Diagnosis, Treatment, Therapy and Future Perspectives
Hamid Rashidzadeh, Hossein Danafar, Hossein Rahimi, et al.
Nanomedicine (2021) Vol. 16, Iss. 6, pp. 497-516
Open Access | Times Cited: 70

Disease-drug and drug-drug interaction in COVID-19: Risk and assessment
Devendra Kumar, Neerja Trivedi
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111642-111642
Open Access | Times Cited: 66

Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study
Yajie Meng, Min Jin, Xianfang Tang, et al.
Applied Soft Computing (2021) Vol. 103, pp. 107135-107135
Open Access | Times Cited: 64

Scroll to top